The Bill & Melinda Gates Foundation has unveiled its ambitious plans for 2026, announcing a record $9 billion operating budget aimed at addressing global...
Atossa Therapeutics, Inc. has received a “Study May Proceed” letter from the U.S. Food and Drug Administration (FDA) for its investigational new drug application...